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We inve~tlllated th~ influence of the thyroid hormone ~tatus on ill© levels of protein kinase~', C [PKC) and A {PKA) in the soluble fraction of rat 
liver, The im)nunodelectabl¢ PKC level in hypothyroid liver was elevated ?.7.fold, wherea~ the: phorhol.ester bindin~ capacity and the immuno- 
detectable =.PKC level were increased 2.4. and 2.6.f`old, respectively. Conversely, in hypothyroid ~ivers the abundance of the reliulatory tyl~= 1
and the eat=tlytl¢ subunits of PKA were lowered to 421X, of the euthyi,oid level as d~termined by immunoblottinl; and by measurinB the substrate 
~peeifie pho~phorylation rate of PKA. These chan@s in the PKC (rod PKA level= were reversible upon treatment with 0,5 l~tl T J I00  [t body weight 
for 2~21 days, The thyroid it.tie dependent altera,,ion~ in hepatic PKC and PKA levels may be responsible for the known chanBes in the response 
of' hcpatocytes to other h r~rmonal stimuli n hypothyroidism, 
Protein kin.~ C: Protein kinase A: Thyroid hormone; Rat F.ver; Hypothyroidism 
1, INTRODUCTION 
Thyroid hormones exert most, if not all of their ac- 
tions by binding to nuclear receptors, thereby 
regulating the expression of specific genes [I]. It has 
been estimated that approximately 8°7o of the hepatic 
genes are regulated by thyroid hormones in vivo [2]. 
Recently, thyroid hormones have been shown to 
regulate the mRNA levels of specific G.protein 
subunits in adipose tissue and heart in vivo [3,4] pro- 
viding evidence for a modulation of transmembrane 
signalling of other hormones by thyroid hormones [5]. 
on PKA, no evidence has been presented on the in- 
fluence of thyroid hormones on the PKC levels in any 
organ. Protein kinase C is a family of enzymes encom- 
passing at least 7 subspecies, which has been shown to 
mediate and modulate transmembrane signalling and 
which is proposed to play a crucial role in governing 
cell metabolism and growth [9]. Choosing the liver as 
an important arget organ of thyroid hormone action 
we investigated whether the levels of ~-,/5'-, ~,-PKC and 
PKA type I or II are altered in the liver cytosol of 
hypothyroid rats and whether these changes can be 
reversed by treatment with L-thyroxine (T~). 
The signal transduction regularly results in the activa- 
tion of various protein kinases. The phosphorylation of
serine, threonine and tyrosine residues by these en- 
zymes has been demonstrated to be a common cellular 
mechanism for regulating ene transcription, cell divi- 
sion, membrane transport and metabolic pathways [6]. 
Thyroid hormones have been reported to stimulate the 
phosphorylation or dephosphorylation f multiple rat 
liver cytosolic proteins [7]. A 1.5-fold increase in type 
I cyclic AMP dependent protein kinase (PKA type I) 
activity in the liver of hyperthyroid compared to 
hypothyroid rats has been demonstrated by elec- 
trophoresis of cytosolic proteins followed by 
phosphorylation assays [8]. In contrast o the studies 
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2. MATERIALS AND METHODS 
2,1, Animals 
25 n~ale Wistar rats (100-120 g) were randomized into 5 different 
treatment groups and were rendered hypothyroid by feeding an 
iodine depleted iet and by adding 1% KCIO4 to the drinking water 
for 35 days. 0.107o 6t~-propyl-2-thiouracil was added to the diet for the 
first 6 days (modified from [2]). Five control rats were maintained on 
the iodine depleted cllow with 1 ppm potassium iodide added to the 
drinking water. The free T4 and total L-triiodothyronine s rum levels 
in the hypothyroid group were 1 ± 0.0°70 and 13 ± 4°70 of the 
euthyroid (iodide substituted) group, respectively. The hypothyroid 
animals of 4 Of the 5 groups were daily substituted orally with 0.5 ag 
Ta/IO0 g body weight for 2, 5, 9 and 21 days, respectively. Vehicle 
was administered to one hypothyroid and the iodine-substituted 
euthyroid group for ! ! and 22 days, respectively. While under a short 
ether anesthesia, the liver was excised and placed into ice.cold buffer. 
This protocol has been approved by the Committee on Animal Care 
and Use of the Canton Basel-Stadt. 
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Fig. I. Time course or the PKC level in tl~¢ rat liver cytosol as detected by a polyclonal antiserum agains.! PKC upon replacement of hypothyroid 
rats with 0.5.~g Tall00 g body weightld over 2, 5, 9 and 21 clays. (A] Amoradiograph of the imml=noblot or ] random samples from each 
treatment group. (B) Densitometric quan(itation of all samples (n - 5) from each treatment group, The results were normalized to the hypothyroid 
group. 
2,2. Preparation of cytosol and immunoblotting 
Two grams of liver were homogenized in a buffer containing 0,3 M 
sucrose, lOmM EGTA, 2 mM EDTA, 10°70 glycerol, 20raM 
HEPES, 13 mM 2.mercaptoethanol, 2,ug/ml aprotinin, 50,ug/ml 
leupeptin, pH 7,5. Cytosol was prepared by centrifugation of the 
homogenate for 15 rain at 1000 x g; the supernatant was centrifuged 
for 60 rain at t00000 x g. "rhe cytosols were diluted to the same pro- 
tein concentration, For SDS polyaerylamide gel electrophoresis 
(SDS-PAGE) of cytosolic proteins the samples were supplemented 
with 3°'/0 SDS and boiled, 
SDS-PAGE (60~g protein/lane) and immunoblotting were per- 
|'ormed as described [10], The characterization a d immunopurifica. 
lion of the polyclonal antiserum against pig brain PKC have been 
described previously [10l. The monoclonal anti.PKC antibodies 
against the or, ,6' and r subspecies were purchased from Seikagaku 
Kogyo Co,, Ltd (Tokyo, Japan) and used in I : 200 dilutions. Pure 
PKA regulatory type 1, type 11 and catalytic subunits (Rt, Rm C) and 
the corresponding antisera have been characterized earlier [11], The 
membranes were developed with the appropriate ~Z~l-labelled second 
antibody, The autoradiographs were quantitated by scanning den. 
sitometry; if possible the optical density of the specific band was nor- 
malized to that of an unspecific band, 
2,3, Other methodx 
[JHlPhorboldibutyrate (PDBu) binding capacity was analyzed and 
quantitated as described previously [12l; PKA activity in lhe cytosol 
was determined by measuri.g the phosphorylation rate of the PKA- 
specific substrate kemptid¢ in the presence of ['rJaPIATP as describ- 
ed [l l] ,  Protein concentrations were determined by the Biuret 
method using an albumin standard, The results are expressed as 
mean ± SEM. 
3, RESULTS 
3.1. Analysis o f  PKC levels 
In  euthyro id  ra ts  o~.PKC was the  pr imary  fo rm o f  
. . . .  enzyme detected  by  the  i so type ,spec i f i c  
monoc lona l  ant ibod ies .  Us ing  a po lyc lona l  ant i serum 
the  level  o f  cy toso l i c  PKC in the l ivers  o f  hypothyro id  
rats  was found to  be  increased  7 .7 - fo ld  compared  to  the  
euthyro id  group .  The  PKC level dec l ined  by 46% a f ter  
admin is ter ing  T4  to hypothyro id  ra ts  for  2 days  
Table I 
Time course of the PKC and PKA levels in the tiver cytosol of T4.treated hypothyroid rats. 
The results were normalized to the hypothyroid group and expressed in percents 
Hypo- +2d T4 +Sd T4 ~-gd T4 +21d T4 Euthyroid 
thyroid 
ce-PKC (IA) 100 -,- 8 71 :z 10' 72 :I: 15' 70 + 8* 66 :t: 8 '  39 -,- 7. 
PDBu binding 100 ± 10 81 + 12 65 ± 9* N.D, 58 ± 3* 42:1: 6* 
PKA-C (IA) 100 ± 5 118 "~ 15 131 + 19 147 :t: 17' 186 ± 32* 242 m 24* 
PKA-Rt (IA) i00 ± i i  89 ± 5 125 "1- 18' 145 :t: 31 188 :~ 17' 238 :e 29* 
Kemptide assay 100 :t: 7 140 5: 5* 104:1:5 N.D. 137 ± 7* 155 ,t- 12" 
N.D. = not determined, IA = lmmunoactivity, * P < 0.05 vs hypothyroid (two-sided 
Mann-Whitney U-test), ~.PKC levels were too low for reliable quantitation. ~,-PKC and Rt~ 
subunits could not be detected. 
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(Fill. I~), The PDBu bindin¢ capacity was elevated 2,4- 
fold in the liver of hypothyroid respective to euthyroid 
rats, Changes in the tt-PiCC subspecies as detected by 
immunoblottin~ with a monoclonal antibody closely 
followed the alterations in PDBu bindinlj (Table 1), 
3.2. Analysis of  Rt, R .  and C subunits of  PK,,I 
The presence of  type 1 and II isoenzyme in rat liver 
has been demonstrated previou~i:/ 1131 and in the pre- 
sent study the Rh R .  and Csubunits  of PKA were iden. 
tiffed on immunoblots on the basis of their apparem 
molecular weight and the comigration with the pure 
subunits. In hypothyroid rats the content of  R~ and C 
in the liver was reduced to 42010 of the emhyroid level, 
Following T., treatment he immunologically detected 
levels of  regulatory type I and catalytic subunits as well 
as the kemptide pl~osphorylation rate increased in 
parallel (Table I), 
4, DISCUSSION 
Although the presence of PKC in the rat liver is well 
established [14] the increase in the PKC level in the liver 
cytosol o f  hypothyroid rats is a novel finding, The 
elevated PKC level was significantly reduced after 2 
days of T.~ treatment, The parallel changes in im- 
munoactive ~-PKC and PDBu binding as well as the 
lack of  any detectable changes in ,6'-PKC and the 
absence of ~,-PKC suggest hat mainly the c~ subspecies 
is increased in hypothyroidism, While the ce-PKC levels 
were increased 2.4-fold in hypothyroidism, the total 
PKC content as quantitated with a oolyclonal an- 
tiserum directed against denatured PKC resulted in a 
7.7-fold increase. This discrepancy may be due to the 
presence of additional forms of PKC (6-. [-I: 'KC) which 
can be detected by the antiserum (unpublished results). 
It has been shown that .('-PKC does not bind PDBu and 
is not recognized by the monoclonal antibody raised 
against native ce.PKC (R, Imber, personal com- 
munication). 
Preliminary evidence suggests, that changes in the 
PKC levels occur also in the brain, heart and kidney of  
hypothyroid rats as compared to euthyroid animals 
(data not shown). The functional consequences o f  an 
increased PKC content in hypothyroidism can only be 
speculated upon. Phorbol.myristate-acetate (PMA),  an 
activator of PKC, is known to stimulate the expression 
of  the proto-oncogenes c-myc and c-fos [15]. Increased 
expression of c-myc in the myocardium of hypothyroid 
rats has been described [16]; this change would be in ac- 
cordance with increased PKC activity in this organ. An 
increased tissue content of PKC could inhibit 
t ransmembrane signalling, e.g. of ~ agonist_s, 
vasopressin, angiotensin II by desensitization of  the 
phosphatidylinositol pathway, since PKC is known to 
down-regulate the signals which lead to i ts  activation 
[15,17]. These considerations are supported by 
evidence demonstrating an inhibition o f  the effect of 
these hormones on rat hepatocytes after pretreatment 
whh PMA [17=20]. The blunted [llycogenolytic 
response to a,= agonists el' hepatocytes from 
hypothyroid rats might be due in part to the 
homclogous desensiti~.ation of the diacylglycerol/Ca =* 
pathway by increased PKC levels [21], 
Earlier studies have demonstrated the presence o f  the 
Rt and R=t isotypes of PKA in the cytosol of rat liver 
[13]. In the present study, the Rt and C subunits of  
PKA and the kemptide phosphorylat ion rate increased 
with the duration of  T.~ replacement of hypothyroid 
rats, These thyroid state dependent alterations in PKA 
levels confirm earlier studies usin~ different methods 
[8]. With the polyclonal antiserum used, the RH subunit 
could not be reliably detected in the liver cytosol; 
however, the close quantitative correlation between 
changes in the Rt and C subunits renders major altera- 
tions in the level of  Re1 unlikely. 
In conclusion, these results indicate that the hepatic 
levels of 2 protein kinases are dependent on the thyroid 
state of  the animal; in hypothyroidism PKC levels are 
increased whereas PKA levels are decreased. These 
alterations may account for modif ied cellular responses 
to other hormonal  stimuli during thyroid hormone 
deficiency. The mechanism by which thyroid hormones 
regulate the hepatic PKC and PKA content in vivo re- 
mains to be elucidated. 
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